JNJ

Johnson & Johnson (JNJ) Stock Price

Closed
JNJ
$285.75
+$2.23(+0.78%)

Content updated: 2026-11-15 18:47:29

Yesterday's Close
$283.52
Today's Open
$285.00
Today's High
$288.10
Today's Low
$284.09
Volume
8.96M shares
52-Week Range
$199.90-$288.10

As of 2026-11-15 18:47:29, Johnson & Johnson (JNJ) was quoted at $285.75, a change of +$2.23 (+0.78%) from the previous close. The day's range was $284.09–$288.10, and the 52-week range was $199.90–$288.10.

Past 1W+2.91%Period Low $276.20Period High $288.10
Past 1M+11.40%Period Low $242.80Period High $288.10
Past 3M+10.42%Period Low $242.80Period High $288.10
Past 1Y+46.72%Period Low $193.55Period High $288.10

About Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Ticker / Exchanges
JNJ / NYSE
Industry / Sector
Drug Manufacturers - General / Healthcare
CEO
Joaquin Duato
Headquarters
New Brunswick,NJ,US
Official Website
https://www.jnj.com
Listing Date
--

Recent Company Events

  • 2027-01-26
    Earnings Report · ExpectedOn 2027-01-26, the 2026/Q4 earnings report is expected to be released.

Johnson & Johnson (JNJ) Derivatives Trading

Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

JNJUSDTTrade
Perpetual Futures

Contracts based on stock prices, with no expiration date. They support 24/7 long, short, and leveraged trading without holding the underlying shares. Be aware of funding fees and liquidation risk.

JNJG/USDTTrade
TokenStocks

Onchain digital assets that track stock prices, including gStocks and xStocks. They support 24/7 trading and onchain transfers. Holding these tokens is not the same as holding the underlying shares directly. Specific rights are subject to the product rules.

Johnson & Johnson (JNJ) Company Financials

Valuation and Shares

Market Cap
$688.75B
P/E Ratio (TTM)
43.42
P/B Ratio
8.43
Shares Outstanding
2.40B shares
Float Shares
2.40B shares
Dividend Yield (TTM)
1.85%

Latest Reported Financials

2026 Q3 Financials

Report Release Date: 2026-10-13

Operating Revenue (Actual)

$25.39B

Same Period Last Year: +5.86%

Earnings per Share (Actual)

$2.59

Same Period Last Year: -7.50%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$79.99B$85.15B$88.82B$94.19B
Net Profit$17.94B$35.15B$14.06B$26.80B
Operating Cash Flow$21.19B$22.79B$24.26B$24.53B

Learn

Gate Learn Articles

What Is Johnson & Johnson (JNJ)? A Complete Guide to the Global Healthcare Giant and Innovative Drug EcosystemJohnson & Johnson (JNJ) is a global healthcare leader based in New Jersey, United States. Established in 1886, the company operates across innovative pharmaceuticals, medical devices, and consumer health, positioning itself as one of the world’s largest general healthcare groups. Over more than a century, Johnson & Johnson has transformed from a traditional medical supplies manufacturer into a global life sciences enterprise, with a core focus on pioneering drug research and advanced medical technologies.2026-11-04
How Johnson & Johnson Expands Its Innovative Drug BusinessJohnson & Johnson (JNJ) stands as a global leader in healthcare, with its pharmaceutical division, Innovative Medicine, concentrating on high-value therapeutic areas including immune diseases, oncology, neuroscience, cardiovascular, and infectious diseases. The company drives sustained growth through innovative drug development. With the divestiture of its consumer health segment and an increased focus on medical innovation, the pharmaceutical Zones have become the central engine powering JNJ’s future growth.2026-11-04
How AI Is Transforming Healthcare: Johnson & Johnson’s Digital Health StrategyJohnson & Johnson (JNJ) is a global leader in healthcare, with operations spanning innovative pharmaceutical research and development, medical device manufacturing, and comprehensive health solutions. The company holds a prominent position within the worldwide medical supply chain. In recent years, as artificial intelligence (AI) technology has advanced, Johnson & Johnson has actively pursued AI applications in drug discovery, clinical development, medical data analytics, and patient management, leveraging digital technologies to increase the efficiency of medical innovation.2026-11-04

JNJ FAQ

What is the current stock price of Johnson & Johnson (JNJ)?

x
As of 2026-11-15 18:47 (UTC+8), the latest available quote for Johnson & Johnson (JNJ) is $285.75 USD, with a change of +$2.23 USD (+0.78%) from the previous trading day's close. Current market status: Closed.

Which exchange is JNJ listed on?

x

How has Johnson & Johnson stock performed over the past month?

x

What is the market cap of Johnson & Johnson?

x

What are Johnson & Johnson's latest financial results?

x

What factors may affect the stock price of Johnson & Johnson (JNJ)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.